UBS Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $573M | Buy |
|
|||||
|
2025
Q1 | $587M | Buy |
|
|||||
|
2024
Q4 | $544M | Buy |
|
|||||
|
2024
Q3 | $395M | Buy |
|
|||||
|
2024
Q2 | $272M | Sell |
|
|||||
|
2024
Q1 | $413M | Buy |
|
|||||
|
2023
Q4 | $250M | Sell |
|
|||||
|
2023
Q3 | $402M | Buy |
|
|||||
|
2023
Q2 | $394M | Buy |
|
|||||
|
2023
Q1 | $415M | Sell |
|
|||||
|
2022
Q4 | $491M | Buy |
|
|||||
|
2022
Q3 | $388M | Sell |
|
|||||
|
2022
Q2 | $454M | Sell |
|
|||||
|
2022
Q1 | $467M | Sell |
|
|||||
|
2021
Q4 | $467M | Sell |
|
|||||
|
2021
Q3 | $445M | Buy |
|
|||||
|
2021
Q2 | $480M | Buy |
|
|||||
|
2021
Q1 | $376M | Sell |
|
|||||
|
2020
Q4 | $416M | Buy |
|
|||||
|
2020
Q3 | $366M | Buy |
|
|||||
|
2020
Q2 | $355M | Sell |
|
|||||
|
2020
Q1 | $437M | Sell |
|
|||||
|
2019
Q4 | $652M | Buy |
|
|||||
|
2019
Q3 | $336M | Sell |
|
|||||
|
2019
Q2 | $341M | Buy |
|
|||||
|
2019
Q1 | $260M | Sell |
|
|||||
|
2018
Q4 | $299M | Sell |
|
|||||
|
2018
Q3 | $504M | Buy |
|
|||||
|
2018
Q2 | $432M | Sell |
|
|||||
|
2018
Q1 | $499M | Sell |
|
|||||
|
2017
Q4 | $529M | Buy |
|
|||||
|
2017
Q3 | $482M | Sell |
|
|||||
|
2017
Q2 | $496M | Buy |
|
|||||
|
2017
Q1 | $410M | Sell |
|
|||||
|
2016
Q4 | $472M | Buy |
|
|||||
|
2016
Q3 | $409M | Buy |
|
|||||
|
2016
Q2 | $356M | Buy |
|
|||||
|
2016
Q1 | $308M | Sell |
|
|||||
|
2015
Q4 | $354M | Buy |
|
|||||
|
2015
Q3 | $241M | Sell |
|
|||||
|
2015
Q2 | $290M | Sell |
|
|||||
|
2015
Q1 | $287M | Buy |
|
|||||
|
2014
Q4 | $255M | Buy |
|